Lataa...
Should Restrictions Be Relaxed for Metformin Use in Chronic Kidney Disease? No, We Should Never Again Compromise Safety!
Metformin is and has been considered as first-line therapy for type 2 diabetes for over a quarter of a century. Like other biguanides, metformin can cause a lactic acidosis that is exceptionally rare but fatal. The likelihood of metformin-associated lactic acidosis is substantially higher in patient...
Tallennettuna:
| Julkaisussa: | Diabetes Care |
|---|---|
| Päätekijät: | , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
American Diabetes Association
2016
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4915554/ https://ncbi.nlm.nih.gov/pubmed/27330129 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/dc15-2327 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|